1. Home
  2. ALUR vs SOND Comparison

ALUR vs SOND Comparison

Compare ALUR & SOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALUR
  • SOND
  • Stock Information
  • Founded
  • ALUR 2009
  • SOND 2014
  • Country
  • ALUR United States
  • SOND United States
  • Employees
  • ALUR N/A
  • SOND N/A
  • Industry
  • ALUR
  • SOND Hotels/Resorts
  • Sector
  • ALUR
  • SOND Consumer Discretionary
  • Exchange
  • ALUR Nasdaq
  • SOND Nasdaq
  • Market Cap
  • ALUR 22.8M
  • SOND 23.2M
  • IPO Year
  • ALUR N/A
  • SOND N/A
  • Fundamental
  • Price
  • ALUR $2.69
  • SOND $1.83
  • Analyst Decision
  • ALUR Strong Buy
  • SOND
  • Analyst Count
  • ALUR 3
  • SOND 0
  • Target Price
  • ALUR $22.83
  • SOND N/A
  • AVG Volume (30 Days)
  • ALUR 857.0K
  • SOND 43.5K
  • Earning Date
  • ALUR 05-14-2025
  • SOND 06-17-2025
  • Dividend Yield
  • ALUR N/A
  • SOND N/A
  • EPS Growth
  • ALUR N/A
  • SOND N/A
  • EPS
  • ALUR N/A
  • SOND N/A
  • Revenue
  • ALUR $28,304,000.00
  • SOND $624,458,000.00
  • Revenue This Year
  • ALUR N/A
  • SOND $28.50
  • Revenue Next Year
  • ALUR $49.35
  • SOND $17.62
  • P/E Ratio
  • ALUR N/A
  • SOND N/A
  • Revenue Growth
  • ALUR N/A
  • SOND 8.32
  • 52 Week Low
  • ALUR $2.15
  • SOND $0.88
  • 52 Week High
  • ALUR $88.75
  • SOND $10.50
  • Technical
  • Relative Strength Index (RSI)
  • ALUR 49.19
  • SOND 36.71
  • Support Level
  • ALUR $2.35
  • SOND $1.77
  • Resistance Level
  • ALUR $3.00
  • SOND $1.86
  • Average True Range (ATR)
  • ALUR 0.26
  • SOND 0.11
  • MACD
  • ALUR -0.01
  • SOND -0.00
  • Stochastic Oscillator
  • ALUR 37.36
  • SOND 22.22

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

About SOND Sonder Holdings Inc.

Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.

Share on Social Networks: